Haupeltshofer, S., Mencl, S., Szepanowski, R. D., Hansmann, C., Casas, A. I., Abberger, H., Hansen, W., Blusch, A., Deuschl, C., Forsting, M., Hermann, D. M., Langhauser, F., & Kleinschnitz, C. (2024). Delayed plasma kallikrein inhibition fosters post-stroke recovery by reducing thrombo-inflammation. Journal of Neuroinflammation, 21(1), Article 155. https://doi.org/10.1186/s12974-024-03149-w
Pacheco Pachado, M., Casas, A. I., Elbatreek, M. H., Nogales, C., Guney, E., Espay, A. J., & Schmidt, H. H. H. W. (2023). Re-Addressing Dementia by Network Medicine and Mechanism-Based Molecular Endotypes. Journal of Alzheimer's Disease, 96(1), 47-56. Article 230694. https://doi.org/10.3233/JAD-230694
Palomino-Antolín, A., Decouty-Pérez, C., Farré-Alins, V., Narros-Fernández, P., Lopez-Rodriguez, A. B., Álvarez-Rubal, M., Valencia, I., López-Muñoz, F., Ramos, E., Cuadrado, A., Casas, A. I., Romero, A., & Egea, J. (2023). Redox Regulation of Microglial Inflammatory Response: Fine Control of NLRP3 Inflammasome through Nrf2 and NOX4. Antioxidants, 12(9), Article 1729. https://doi.org/10.3390/antiox12091729
Szepanowski, R. D., Haupeltshofer, S., Vonhof, S. E., Frank, B., Kleinschnitz, C., & Casas, A. (2023). Thromboinflammatory challenges in stroke pathophysiology. Seminars in Immunopathology, 45(3), 389-410. https://doi.org/10.1007/s00281-023-00994-4
Petraina, A., Elbatreek, M., Neullens, C. T., Saridaki, T., Dao, V. T.-V., Casas Guijarro, A., & Schmidt, H. (2023). Understanding (apo-) soluble guanylate cyclase allosterism and its therapeutic implications. DrugRxiv. https://doi.org/10.14293/S2199-1006.1.SOR-.PPW9FFL.v2
Mohamed Mamdouh Abdelkareem Gomaa, Z., Anastasi, E., Hassan, A., Boltze, J., Elbatreek, M., Nogales Calvo, C., Pacheco Pachado, M., Petraina, A., Piper, Z., Rodriguez Gonzalez, A., Wipat, A., Silverman, E., Casas Guijarro, A., Guney, E., Schmidt, H., REPO-TRIAL, & REPO4EU consortia (2023). Why the way we define diseases prevents innovation and precision medicine. DrugRxiv. https://doi.org/10.14293/S2199-1006.1.SOR-.PPCFYDY.v1
Petraina, A., Elbatreek, M., Neullens, C. T., Saridaki, T., Dao, V. T.-V., Casas Guijarro, A., & Schmidt, H. (2023). On a revised pharmacology of apo-soluble guanylate cyclase and its therapeutic implications. DrugRxiv. https://doi.org/10.14293/S2199-1006.1.SOR-.PPW9FFL.v1
Casas, A. I., Hassan, A. A., Manz, Q., Wiwie, C., Kleikers, P., Egea, J., López, M. G., List, M., Baumbach, J., & Schmidt, H. H. H. W. (2022). Un-biased housekeeping gene panel selection for high-validity gene expression analysis. Scientific Reports, 12(1), Article 12324. https://doi.org/10.1038/s41598-022-15989-8
De Meyer, S. F., Langhauser, F., Haupeltshofer, S., Kleinschnitz, C., & Casas, A. I. (2022). Thromboinflammation in Brain Ischemia: Recent Updates and Future Perspectives. Stroke, 53(5), 1487-1499. https://doi.org/10.1161/STROKEAHA.122.038733
Palomino-Antolin, A., Narros-Fernández, P., Farré-Alins, V., Sevilla-Montero, J., Decouty-Pérez, C., Lopez-Rodriguez, A. B., Fernández, N., Monge, L., Casas, A. I., Calzada, M. J., & Egea, J. (2022). Time-dependent dual effect of NLRP3 inflammasome in brain ischaemia. British Journal of Pharmacology, 179(7), 1395-1410. https://doi.org/10.1111/bph.15732